Avant Immunotherapeutics' CETP vaccine is effective in rabbit models of atherosclerosis April 20, 1999 No Comments
SBR-170: a new bioreductive alkylating agent selected for further evaluation April 20, 1999 No Comments
News from FASEB: novel botanical product for treatment of Alzheimer's disease April 20, 1999 No Comments
New compound for BPH in active preclinical development at Merck & Co. and Synaptic April 20, 1999 No Comments
RSS